Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment.

Autor: Van Audenaerde, Jonas RM1,2, Marcq, Elly1, Scheidt, Bianca2, Davey, Ashleigh S2, Oliver, Amanda J2, De Waele, Jorrit1, Quatannens, Delphine1, Van Loenhout, Jinthe1, Pauwels, Patrick1,3, Roeyen, Geert4, Lardon, Filip1, Slaney, Clare Y2,5, Peeters, Marc1,6, Kershaw, Michael H2,5, Darcy, Phillip K2,5, Smits, Evelien LJM1,7 evelien.smits@uantwerpen.be
Zdroj: Clinical & Translational Immunology. 2020, Vol. 9 Issue 8, p1-16. 16p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje